Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for k_a Estimation

This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Non-small cell lung cancer in adults under 40 years of age].

Revue des maladies respiratoires·2024

Same author

Benefits of cardiopulmonary resuscitation in cancer patients.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2024

Same author

[Severe complications of systemic treatment in thoracic oncology].

Revue des maladies respiratoires·2024

Same author

[Respiratory cancer diseases: Which role for intensive care ?]

Revue des maladies respiratoires·2023

Same author

[The role of the intensive care unit after thoracic surgery].

Revue des maladies respiratoires·2022

Same author

[The role of prophylactic cranial irradiation in small cell lung cancer].

Revue des maladies respiratoires·2021

Search research articles

Related Experiment Video

Updated: Jun 10, 2026

A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules

A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules

Published on: May 19, 2023

[Pulmonary nodule: a bayesian approach].

¹Département des Soins Intensifs et d'Oncologie Thoracique, Institut Jules Bordet, Centre des Tumeurs de l'U.L.B., Bruxelles. ap.meert@bordet.be

Revue Medicale De Bruxelles

|August 4, 2010

Summary

The Bayesian approach aids in distinguishing malignant solitary pulmonary nodules (SPNs) from benign ones. Incorporating fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET) scans significantly improves cancer probability estimation in SPNs.

More Related Videos

Three-Dimensional Reconstruction for the Whole Lung with Early Multiple Pulmonary Nodules

Three-Dimensional Reconstruction for the Whole Lung with Early Multiple Pulmonary Nodules

Published on: October 13, 2023

$Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy$

Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy

Published on: January 10, 2025

Related Experiment Videos

Last Updated: Jun 10, 2026

A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules

A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules

Published on: May 19, 2023

Three-Dimensional Reconstruction for the Whole Lung with Early Multiple Pulmonary Nodules

Three-Dimensional Reconstruction for the Whole Lung with Early Multiple Pulmonary Nodules

Published on: October 13, 2023

$Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy$

Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy

Published on: January 10, 2025

Area of Science:

Pulmonology
Radiology
Oncology

Background:

Solitary pulmonary nodule (SPN) is a frequent clinical finding, often detected incidentally.
Prevalence of SPNs in lung cancer screening ranges from 8-50%, with malignancy rates of 1-13%.

Observation:

The Bayesian approach utilizes likelihood ratios (LRs) from clinical and radiological data to estimate the probability of cancer (Pca) in SPNs.
Fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET) scans provide high sensitivity (90%) and specificity (83%) for malignancy detection.

Findings:

FDG-PET scans yield higher LRs for malignancy compared to most traditional clinical and radiological factors.
The Bayesian model incorporating FDG-PET scan results offers improved accuracy in Pca estimation for SPNs.

Implications:

Integrating FDG-PET scans into the Bayesian approach is crucial for accurate SPN evaluation.
This method can optimize surgical decisions, ensuring treatment for malignant nodules while avoiding unnecessary surgery for benign ones.